Taltz subcutaneous injection 80 mg syringe

Taltz subcutaneous injection 80 mg syringe, from Eli Lilly Japan, contains ixekizumab (genetical recombination). This injectable medication is used for autoimmune diseases, including moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis. This product is an 80 mg syringe with YJ code 3999442G1023 and is specified as 210mg 1.5mL per tube.